← Back to Clinical Trials
Recruiting NCT07818382

NCT07818382 Assessing the Relationships Between Parent-child Eating in the Absence of Hunger, Appetitive Traits, and Food Parenting.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07818382
Status Recruiting
Phase —
Sponsor State University of New York at Buffalo
Condition Eating in Absence of Hunger
Study Type INTERVENTIONAL
Enrollment 70 participants
Start Date 2026-07-08
Primary Completion 2027-07-08

Eligibility & Interventions

Sex All sexes
Min Age 5 Years
Max Age 99 Years
Study Type INTERVENTIONAL
Interventions
Eating in Absence of Hunger (EAH) paradigm

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 70 participants in total. It began in 2026-07-08 with a primary completion date of 2027-07-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This is a single-visit study consisting of parent-child dyads attending a 2-hour session. The purpose of this research is to use the eating in absence of hunger (EAH) paradigm, to evaluate the association between parental EAH, food parenting, appetitive traits, and children EAH. It is hypothesized that both the parental EAH and the controlling food parenting will have a significant positive association with the children EAH. The results from this study will help us understand how food parenting, appetitive traits, and parental EAH influences the children EAH.

Eligibility Criteria

Inclusion Criteria: Parent/ guardian: * Age \> 18 years old. * Have a child between the ages of 5 - 11. * Must be responsible for feeding their eligible child at least 50% of the time. * Willing and able to eat the meal and snacks provided. * Fluent in English. Children: * If parent/ guardian is eligible and participating in the study. * Child is aged 5 - 11 years. * Child is not currently diagnosed with a clinical eating disorder (ED). * Willing and able to eat the meal and snacks provided. * Child is not on any medications or has any condition that could influence the child's taste, appetite, or olfactory sensory responsiveness. Exclusion Criteria: Parent/ guardian: * Age is \>18 years old. * Their child is determined ineligible (based on age). * Is responsible for feeding their eligible child \< 50% of the time. * Not fluent in English. * On medication that could influence their eating or feeding behaviors. * If the parent/ guardian is pregnant * Allergic or unable to eat the study food presented. * History of choking (without gagging). Children: * Their parent/ guardian is not eligible nor participating in the study. * Below the age of 5 and above the age of 11. * Current diagnosis of a clinical eating disorder (ED). * Allergic or unable to eat the study food presented. * Medications or conditions that could influence the child's taste, appetite, or olfactory sensory responsiveness. * History of choking (without gagging).

Contact & Investigator

Principal Investigator

Katherine N Balantekin, PhD, RD

PRINCIPAL INVESTIGATOR

University at Buffalo

Frequently Asked Questions

Who can join the NCT07818382 clinical trial?

This trial is open to participants of all sexes, aged 5 Years or older, up to 99 Years, studying Eating in Absence of Hunger. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07818382 currently recruiting?

Yes, NCT07818382 is actively recruiting participants. Visit ClinicalTrials.gov or contact State University of New York at Buffalo to inquire about joining.

Where is the NCT07818382 trial being conducted?

This trial is being conducted at Buffalo, United States.

Who is sponsoring the NCT07818382 clinical trial?

NCT07818382 is sponsored by State University of New York at Buffalo. The principal investigator is Katherine N Balantekin, PhD, RD at University at Buffalo. The trial plans to enroll 70 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology